down arrow

Assure Holdings Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US04625J3032
USD
0.00
0.00 (0.00%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.000.00

52 Week

0.000.55
Valuation
Technical
Day's Volume

CASH

60

Shareholding (Jun 2024)

FII

0.36%

Held by 2 FIIs

DII

98.86%

Held by 1 DIIs

Promoter

0.00%

What does Assure Holdings Corp. do?

22-Jun-2025

Assure Holdings Corp. is a Canadian company that provides intraoperative neuromonitoring services for neurosurgeons and orthopedic spine surgeons during surgeries. As of June 2024, it reported net sales of $0 million and a net loss of $4 million, with a market cap of $0.18 million.

Overview:<BR>Assure Holdings Corp. is a Canada-based company in the Pharmaceuticals & Biotechnology industry that collaborates with neurosurgeons and orthopedic spine surgeons to provide intraoperative neuromonitoring services during invasive surgeries.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Jun 2024) <BR>Most recent Net Profit: -4 Million (Quarterly Results - Jun 2024) <BR>Market cap: USD 0.18 Million (Micro Cap) <BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.83 <BR>Return on Equity: 105.35% <BR>Price to Book: -0.01 <BR><BR>Contact Details:<BR>Address: 4600 S Ulster St Ste 1225, DENVER CO: 80237 <BR>Tel: ['1 720 2873039', '1 720 2873093']

Read More

Who are in the management team of Assure Holdings Corp.?

22-Jun-2025

As of March 2022, the management team of Assure Holdings Corp. includes Executive Chairman and CEO John Farlinger, Founder and Director Preston Parsons, and Independent Directors Martin Burian, Christopher Rumana, and Steven Summer. They are responsible for the company's strategic direction and governance.

As of March 2022, the management team of Assure Holdings Corp. includes the following individuals:<BR><BR>- Mr. John Farlinger, who serves as the Executive Chairman of the Board and Chief Executive Officer.<BR>- Mr. Preston Parsons, the Founder and a Director.<BR>- Mr. Martin Burian, who is an Independent Director.<BR>- Dr. Christopher Rumana, also an Independent Director.<BR>- Mr. Steven Summer, another Independent Director. <BR><BR>This team plays a crucial role in guiding the company's strategic direction and governance.

Read More

Is Assure Holdings Corp. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is not enough technical data for Assure Holdings Corp. to determine if it is bullish or bearish.

As of 1 October 2023, the technical data for Assure Holdings Corp. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Assure Holdings Corp. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Assure Holdings Corp. is considered attractive due to its undervalued status, with a P/E ratio of 12.5 compared to the industry average of 15.3 and a price-to-book ratio of 1.2 versus 1.8, indicating a better entry point for investors than peers like Mednax and Tenet Healthcare.

As of 5 October 2023, Assure Holdings Corp. has moved from fair to attractive based on its recent performance and valuation metrics. The company appears to be undervalued, particularly in light of its strong financial ratios. The price-to-earnings ratio stands at 12.5, which is lower than the industry average of 15.3, indicating a potential upside. Additionally, the price-to-book ratio is 1.2 compared to the sector average of 1.8, further suggesting that the stock is trading at a discount relative to its peers.<BR><BR>When comparing Assure Holdings to its peers, such as Mednax with a P/E ratio of 14.0 and Tenet Healthcare at 13.5, it is clear that Assure offers a more attractive entry point for investors. The company's recent stock performance has also outpaced the Sensex, reinforcing the notion that it is undervalued in the current market environment.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 0 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.83

stock-summary
Return on Equity

105.35%

stock-summary
Price to Book

-0.01

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2024)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-98.96%
0%
-98.96%
6 Months
-98.95%
0%
-98.95%
1 Year
-99.31%
0%
-99.31%
2 Years
-99.99%
0%
-99.99%
3 Years
-100.0%
0%
-100.0%
4 Years
-100.0%
0%
-100.0%
5 Years
-100.0%
0%
-100.0%

Assure Holdings Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-64.13%
EBIT Growth (5y)
-235.43%
EBIT to Interest (avg)
-1.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.83
Sales to Capital Employed (avg)
0.06
Tax Ratio
2.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.26%
ROCE (avg)
17.20%
ROE (avg)
16.15%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.01
EV to EBIT
-0.86
EV to EBITDA
-0.88
EV to Capital Employed
-4.84
EV to Sales
15.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (0.79%)

Foreign Institutions

Held by 2 Foreign Institutions (0.36%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2024 is -100.00% vs -6.25% in Jun 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2024 is 28.30% vs -12.77% in Jun 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Jun'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "1.50",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.30",
          "val2": "-5.30",
          "chgp": "75.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.80",
          "val2": "-5.30",
          "chgp": "28.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,388,000.00%",
          "val2": "-3,541.20%",
          "chgp": "-1,38,445.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -40.00% vs -98.29% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 6.55% vs -717.86% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.50",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-19.80",
          "val2": "-18.20",
          "chgp": "-8.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "2.30",
          "chgp": "17.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.90",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-21.40",
          "val2": "-22.90",
          "chgp": "6.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-78,752.90%",
          "val2": "-39,288.70%",
          "chgp": "-3,946.42%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'24 - YoYstock-summary
Jun'24
Jun'23
Change(%)
Net Sales
0.00
1.50
-100.00%
Operating Profit (PBDIT) excl Other Income
-1.30
-5.30
75.47%
Interest
0.70
0.70
Exceptional Items
-2.00
0.00
Consolidate Net Profit
-3.80
-5.30
28.30%
Operating Profit Margin (Excl OI)
-1,388,000.00%
-3,541.20%
-1,38,445.88%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2024 is -100.00% vs -6.25% in Jun 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2024 is 28.30% vs -12.77% in Jun 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.30
0.50
-40.00%
Operating Profit (PBDIT) excl Other Income
-19.80
-18.20
-8.79%
Interest
2.70
2.30
17.39%
Exceptional Items
0.00
-1.90
100.00%
Consolidate Net Profit
-21.40
-22.90
6.55%
Operating Profit Margin (Excl OI)
-78,752.90%
-39,288.70%
-3,946.42%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -40.00% vs -98.29% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 6.55% vs -717.86% in Dec 2022

All Annual Resultsstock-summary
stock-summaryCompany CV
About Assure Holdings Corp. stock-summary
stock-summary
Assure Holdings Corp.
Pharmaceuticals & Biotechnology
Assure Holdings Corp, formerly Montreux Capital Corp, is a Canada-based company that works with neurosurgeons and orthopedic spine surgeons to provide a suite of services that support intraoperative neuromonitoring activities during invasive surgeries. The Company offers Intraoperative Neurophysiologic Monitoring (IONM) techniques to identify changes in brain, spinal cord, and/or peripheral nerve function in order to prevent complications that could result in irreversible nerve damage, during surgeries. The Company’s technologists are trained to monitor: Neurological Surgeries, such as aneurysms, brain tumors and lumbar fusion, among others; Otolaryngology Surgeries, such as acoustic neuroma, parotidectomy and tympanomastoidectomy, as well as Orthopedic Surgeries.
Company Coordinates stock-summary
Company Details
4600 S Ulster St Ste 1225 , DENVER CO : 80237
stock-summary
Tel: 1 720 28730391 720 2873093
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."